» Articles » PMID: 30075569

Clinical Characteristics Associated with Bone Mineral Density Improvement After 1-year Alendronate/vitamin D3 or Calcitriol Treatment: Exploratory Results from a Phase 3, Randomized, Controlled Trial on Postmenopausal Osteoporotic Women in China

Overview
Specialty General Medicine
Date 2018 Aug 5
PMID 30075569
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Baseline and on-treatment characteristics, including age, obesity, calcium intake, and bone turnover markers, may predict the bone mineral density (BMD) response in women with postmenopausal osteoporosis (PMO) to 1 to 2 years of antiresorptive therapy and/or vitamin D supplementation. This study aimed to explore clinical characteristics associated with 12-month BMD improvement in Chinese women with postmenopausal osteoporosis (PMO).In this post hoc analysis of a previous phase 3 multicenter, randomized controlled trial, Chinese PMO women who were treated with once weekly alendronate 70 mg/vitamin D3 5600 IU (ALN/D5600) or once daily calcitriol 0.25 mcg, and had measurements of 1-year lumbar spine BMD (LS-BMD) and on-treatment bone turnover markers (BTMs) were included in the analysis.In Chinese PMO patients on ALN/D5600, 1-year LS-BMD change was negatively correlated with age (β = -0.00084, P < .01), dietary calcium (β = -0.0017, P = .07), and procollagen type 1 N-terminal propeptide (P1NP) change at month 6 (β = -0.000469, P = .0016), but positively with body mass index (BMI) (β = 0.00128, P = .08); baseline P1NP above the median was associated with a significantly greater BMD percentage change at the lumbar spine (P = .02) and the total hip (P = .0001). In the calcitriol group, a significant 1-year LS-BMD increase was associated with BMI (β = 0.0023, P = .02), baseline P1NP (β = 0.00035, P = .0067), history of prior vertebral fracture(s) (β = 0.034, P < .0001) and baseline serum 25(OH)D level (β = -0.00083, P = .02).The presented findings from Chinese postmenopausal osteoporotic women suggested clinically meaningful baseline and on-treatment characteristics predicting BMD improvement after 1 year of ALN/D5600 treatment, which differed from calcitriol treatment with baseline identifiable associations. The study remained exploratory and further accumulation of evidence is needed.

Citing Articles

Efficacy of Danshen injection combined with Calcitriol and Calcium/Vitamin-D for the treatment of osteoporotic fractures: A retrospective case-control study.

Li H, Lin D, Lin H, Liu M, Lu G Pak J Med Sci. 2024; 40(3Part-II):291-296.

PMID: 38356835 PMC: 10862428. DOI: 10.12669/pjms.40.3.8513.


Role of tumor-derived exosomes in bone metastasis.

Li F, Liu J, Xu F, Lin X, Zhong J, Wu F Oncol Lett. 2019; 18(4):3935-3945.

PMID: 31579412 PMC: 6757296. DOI: 10.3892/ol.2019.10776.


The association between CD31Emcn endothelial cells and bone mineral density in Chinese women.

Zhu Y, Ruan Z, Lin Z, Long H, Zhao R, Sun B J Bone Miner Metab. 2019; 37(6):987-995.

PMID: 30919130 DOI: 10.1007/s00774-019-01000-4.

References
1.
Quesada-Gomez J, Diaz-Curiel M, Sosa-Henriquez M, Malouf-Sierra J, Nogues-Solan X, Gomez-Alonso C . Low calcium intake and inadequate vitamin D status in postmenopausal osteoporotic women. J Steroid Biochem Mol Biol. 2012; 136:175-7. DOI: 10.1016/j.jsbmb.2012.10.013. View

2.
Stein E, Ortiz D, Jin Z, McMahon D, Shane E . Prevention of fractures after solid organ transplantation: a meta-analysis. J Clin Endocrinol Metab. 2011; 96(11):3457-65. PMC: 3205901. DOI: 10.1210/jc.2011-1448. View

3.
FitzGerald G, Boonen S, Compston J, Pfeilschifter J, LaCroix A, Hosmer Jr D . Differing risk profiles for individual fracture sites: evidence from the Global Longitudinal Study of Osteoporosis in Women (GLOW). J Bone Miner Res. 2012; 27(9):1907-15. DOI: 10.1002/jbmr.1652. View

4.
Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore C . Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int. 2008; 20(2):239-44. DOI: 10.1007/s00198-008-0650-y. View

5.
Wang Y, Tao Y, HYMAN M, Li J, Chen Y . Osteoporosis in china. Osteoporos Int. 2009; 20(10):1651-62. DOI: 10.1007/s00198-009-0925-y. View